AstraZeneca PLC AZN

GB Pharmaceuticals

$169.64 ▼ -0.99% ($-1.70)

⬇️ Below Yest. Low

Open $170.53

Prev Close $171.34

Day Range $168.44 – $170.74

52W Range $10,784.00 – $15,730.00

Market Cap $197.27B

P/E (TTM) 25.39

Beta 1.36

Div Yield 1.88%

EPS (TTM) $6.69

📋 Company Profile

Industry	Pharmaceuticals
Country	GB
Exchange	LONDON STOCK EXCHANGE
Currency	USD
IPO Date	2007-09-21
Shares Out.	1,551,020,000
Website	astrazeneca.com/ ↗
Phone	442037495000
Employees	96,100
Total Assets	$114.07B
Total Liabilities	$65.36B
Equity	$48.72B

About AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

AstraZeneca PLC is a publicly traded company under the ticker symbol AZN on the LONDON STOCK EXCHANGE, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.